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of all patients with combined carotid and coronary occlu-
sive disease. Least controversial are those patients with
combined symptomatic disease because most authors
advocate simultaneous CEA/CAB. However, the more
controversial group is that with critical asymptomatic
stenosis. With the application of results of the ACAS,3
these patients should derive a long-term benefit of stroke
reduction, but there is no agreement about the optimal
timing of surgery. The options for surgical management of
severe carotid and coronary disease include CEA first then
CAB (staged approach), CEA and CAB simultaneously
(combined approach), and CAB first then CEA (reverse-
staged approach).
METHODS
In 1996 Mackey et al6 reported their experience with
100 consecutive patients undergoing combined CEA/CAB
from 1984 to 1994 at our institution. From 1994 on, in
an effort to further reduce the incidence of perioperative
stroke in CAB patients with significant carotid disease, we
have liberalized our criteria for performing simultaneous
CEA, so that all patients with indications for CEA alone
were offered combined surgery. These indications
included symptom-free patients with > 80% stenosis and
patients who had symptoms with significant ipsilateral 
Significant atherosclerotic disease affecting both the
coronary and carotid arteries is present in a substantial
number of patients1 and has serious implications for surgi-
cal management. Among patients undergoing carotid
endarterectomy (CEA) in the Veterans Affairs Cooperative
Study2 and the Asymptomatic Carotid Atherosclerosis
Study3 (ACAS), 20% and 49%, respectively, of deaths were
due to cardiac causes with myocardial infarction account-
ing for about half. Similarly, the incidence of perioperative
stroke in patients undergoing coronary artery bypass
(CAB) is elevated nearly 10-fold (14%) in those with
severe carotid stenosis.4
The incidence of severe carotid stenosis (> 75%) in
patients undergoing CAB may be as high as 11% to
12%.4,5 Despite this important association, no clear con-
sensus has been developed about the optimal management
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Objective: The optimal management of patients with significant coronary and carotid artery disease remains controver-
sial. Since reporting on a series of 100 patients undergoing combined carotid endarterectomy and coronary artery
bypass (CEA/CAB) 4 years ago, we have liberalized our selection criteria for combined operation. We sought to com-
pare outcomes of the recent cohort of 74 patients and the previous group.
Methods: All patients who underwent CEA/CAB since 1984 have been tracked in a database containing identifying
information, demographic factors, anatomic information, details of surgery, and short- and long-term follow-up data.
We compared the 74 patients (Group 2) undergoing CEA/CAB since 1994 with the previously reported group of 100
patients (Group 1) who underwent CEA/CAB between 1984 and 1994. We examined demographic and comorbidity
factors, presence of cerebrovascular symptoms, degree of contralateral carotid stenosis, and perioperative stroke and
death. Statistical comparisons were made with the χ2 test.
Results: The groups had similar age and sex distributions and similar incidences of hypertension, diabetes, congestive
heart failure, prior myocardial infarction, and hypercholesterolemia. More patients in Group 1 had preoperative tran-
sient cerebral ischemia or monocular blindness (55% vs 31%, P < .002) and preoperative stroke (18% vs 7%, P < .03).
More patients in Group 2 had unilateral asymptomatic carotid artery stenosis (55% vs 18%, P < .001). The incidence
of all perioperative strokes was higher in Group 1 (9% vs 1.4%, P < .035). There were fewer deaths (3% vs 8%) and ipsi-
lateral strokes (0 vs 4%) in Group 2, though these were not statistically significant.
Conclusion: We have liberalized our criteria for performing combined CEA/CAB, such that more than 50% of our
recent patients have asymptomatic unilateral carotid stenosis. This practice is associated with a lower incidence of all
perioperative strokes and a trend toward lower ipsilateral stroke and death. These observations suggest that perioper-
ative stroke after CEA/CAB is related to patient selection and that low-risk patients can undergo CEA/CAB with the
benefits of low morbidity, patient convenience, and cost savings from avoiding a second hospitalization and operation.
(J Vasc Surg 2001;33:1179-84.)
disease (> 50%). This recent cohort comprises 74 consec-
utive patients from 1994 to 1999. Patient data including
demographics, risk factors, comorbidity, and the CEA and
CAB operative data were recorded in a database.
Technical details of the procedure were as follows.
While the saphenous vein was harvested, CEA was per-
formed first through a standard anterior neck incision.
Routine shunting was used in most cases, while the
remaining patients had selective shunting that was based
on electroencephalogram monitoring. All patients had
patch closure of the arteriotomy with Dacron (Thin Wall
Patch; Sulzer Vascutek, Austin, Tex) or saphenous vein,
and the neck wound was closed over a closed-suction
drain when the CEA was completed. Most CEAs in the
recent cohort were performed by two surgeons (J.M.E.
and W.C.M.). A small number of patients underwent CEA
with valve replacement and CAB (n = 3) and are also con-
sidered in this group.
A second CEA was performed in one patient because
of a critical restenosis and contralateral occlusion.
Combined CEA/CAB was performed in stable patients or
those requiring urgent CAB, defined by cardiac ischemia
controlled with heparin or nitroglycerin infusions.
Combined surgery was not considered for those who were
unstable (active cardiac ischemia, hypotension) or who
required CAB as an emergency procedure. Two patients
with critical asymptomatic disease were not offered
CEA/CAB because of excessive medical morbidity, which
was defined by end-stage renal failure, malignancy, or
other serious condition expected to limit survival to less
than 1 to 2 years. Statistical analysis was performed with a
two by two χ2 comparison.
RESULTS
Demographic data for the latest cohort (Group 2) are
shown in comparison with the older cohort (Group 1) in
Table I. Most patients were male, and a history of hyper-
tension and smoking was common. As expected, previous
myocardial infarction and congestive heart failure were
more prevalent compared with groups of patients who
undergo CEA alone.3,6 There were no statistical differ-
ences in any of the comorbidity variables between the two
groups. The incidence of depressed ventricular function
was similar in both groups, but Group 2 had a greater
proportion of patients operated on urgently for coronary
artery disease (47% vs 24%, P < .002).
We examined the relationship between the presence of
preoperative cerebrovascular symptoms and the status of
the contralateral carotid artery between the two cohorts
(Table II). Because patients in Group 2 reflect more liber-
alized indications for combined CEA/CAB, as expected
we observed a greater proportion of symptom-free
patients in Group 2 compared with Group 1 (69% vs 45%,
P < .002). In particular, the proportion of symptom-free
patients with unilateral critical stenosis was much greater
in the recent cohort (55% vs 20%, P < .0001). In all
patients the distribution of disease in the contralateral
carotid artery was similar except for those with occlusion.
Contralateral carotid occlusion was more common in
Group 1 (27% vs 9%, P < .004).
In Table III we examine the relationship of stroke and
death with the degree of stenosis in the contralateral
carotid artery in both cohorts. In Group 1 the stroke and
death rates were 9% and 8%, respectively, and four of nine
strokes were ipsilateral. No statistically demonstrable rela-
tionship was seen between the contralateral degree of
stenosis and stroke or death rates. Although the incidence
of adverse events in each group was small, we did observe
that in patients with contralateral severe stenosis or occlu-
sion, all strokes occurred in the contralateral hemisphere.
Of the 8 deaths, 4 were due to cardiac failure, 2 were due
to stroke, and 1 each was related to coagulopathic hemor-
rhage and respiratory failure.
For Group 2 the stroke and death rates were 1.4% and
2.7%, respectively. No ipsilateral or contralateral strokes
were observed. One patient had a posterior circulation
stroke that caused hemianopia. Because this patient’s ver-
tebral arteries appeared normal on duplex study, this event
was presumed to be a result of embolization from an aor-
tic source. The two deaths were caused by cardiac failure.
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Table I. Demographic data of patients undergoing combined CEA/CAB
Group 1* (n = 100) Group 2† (n = 74) P value
Mean age (y) 68 70 NS
Males 69% 57% NS
Hypertension 73% 81% NS
History of smoking 81% 70% NS
Diabetes mellitus 30% 38% NS
Hypercholesterolemia 42% 51% NS
Congestive heart failure 21% 32% NS
Prior myocardial infarction 55% 41% NS
Ventricular ejection fraction < 50% 34% 39% NS
Urgent CAB 24% 47% .002
*Patients undergoing combined CEA/CAB from 1984 to 1994.
†Patients undergoing combined CEA/CAB from 1994 to 1999.
CAB, Coronary artery bypass; CEA, carotid endarterectomy; NS, not significant.
Table IV summarizes statistically significant differ-
ences between the two groups. Group 1 had a higher pro-
portion of patients with symptoms and those with
contralateral occlusion, whereas Group 2 had a higher
prevalence of symptom-free patients with unilateral steno-
sis. Group 1 had a greater incidence of all strokes and
exhibited a trend toward greater ipsilateral stroke and
greater mortality.
DISCUSSION
Despite the documented efficacy of CEA and CAB
alone in patients with significant vascular disease affecting
the carotid and coronary arteries, controversy exists about
the optimal management when both diseases coexist.
Surgical treatment options include a staged approach (CEA
then CAB), combined procedures, or a reverse-staged
approach, where CAB is done first followed by CEA.
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The staged approach can be problematic because
patients with severe coronary disease are undergoing CEA
without the protective benefits of coronary revasculariza-
tion. In the series by Hertzer et al,7 only 24 (9%) of 275
patients were considered suitable for this approach on the
basis of cardiac risk assessment. Given that cardiac mor-
bidity and mortality are major contributors to periopera-
tive complications after CEA,2,3,6,8 it seems difficult to
justify the staged approach, particularly for patients with
asymptomatic carotid disease.
Hertzer’s group7 also made important observations
about the outcome after reverse-staged operations. With-
in their cohort of 275 patients, 129 with unilateral
asymptomatic carotid stenosis were randomized to com-
bined or reverse-staged CEA/CAB. The composite peri-
operative stroke rate for the reverse-staged group (14%)
was significantly worse than for the combined group
Table II. Distribution of cerebrovascular symptoms and contralateral degree of stenosis for Groups 1 and 2
Contralateral carotid disease
Minimal Moderate Severe Occluded Total
Group 1 (n = 100)
Asymptomatic 5 15 10 15 45
Symptomatic 22 14 7 12 55
Total (%) 27% 29% 17% 27%
Group 2 (n = 74)
Asymptomatic 19 22 7 3 51
Symptomatic 5 4 10 4 23
Total (%) 32% 35% 23% 9%
Degree of stenosis: minimal < 50%, moderate 50%-79%, severe 80%-99%.
Table III. Stroke and death by severity of contralateral carotid stenosis for Groups 1 and 2
Contralateral carotid stenosis
Minimal Moderate Severe Occluded Total
Group 1 (n = 100) 27 29 17 27 100
Stroke: all 3 3 1 2 9
Stroke: ipsilateral 2 2 0 0 4
Stroke: contralateral 1 1 1 2 5
Stroke: all others 0 0 0 0 0
Death 1 4 1 2 8
Stroke rate: all 11.1% 10.3% 5.9% 7.4% 9.0%
Stroke rate: ipsilateral 7.4% 6.9% 0.0% 0.0% 4.0%
Death rate 3.7% 13.8% 5.9% 7.4% 8.0%
Group 2 (n = 74) 24 26 17 7 74
Stroke: all 0 1 0 0 1
Stroke: ipsilateral 0 0 0 0 0
Stroke: contralateral 0 0 0 0 0
Stroke: all others 0 1 0 0 1
Death 1 1 0 0 2
Stroke rate: all 0.0% 3.8% 0.0% 0.0% 1.4%
Stroke rate: ipsilateral 0.0% 0.0% 0.0% 0.0% 0.0%
Death rate 4.2% 3.8% 0.0% 0.0% 2.7%
Degree of stenosis: minimal < 50%, moderate 50%-79%, severe 80%-99%.
(2.8%). Interestingly, the stroke rate for CEA alone in the
reverse-staged group was higher than expected (7.5%),
and they also observed a trend toward reduction in this
stroke risk if the CEA was performed later than 2 weeks
after CAB.
Since 1994 we have adopted a more liberal policy, so
that combined CEA/CAB is considered for all patients
undergoing CAB who have significant carotid artery dis-
ease. We were seeing relatively more patients with asymp-
tomatic but critical carotid stenosis by means of increased
duplex ultrasound screening, and with added impetus
from the results of the ACAS,3 we thought a more aggres-
sive approach could be justified. The combined approach
also provides a more efficient and less costly treatment
strategy by avoiding a second or prolonged hospital stay
and two separate operations.
Numerous reports in the literature document stroke
rates after combined CEA/CAB from 0% to 10%9-11 (see
Rizzo et al for a review12). Differences in patient selection
criteria, severity of disease (both cardiac and carotid), and
other interinstitutional variables make comparisons
between these studies difficult. We therefore sought to
compare outcome after combined CEA/CAB of our
recent series with the previous cohort reported by Mackey
et al in 1996.6 We expected that these groups would have
a comparable severity of cardiac disease and would differ
only by the severity of carotid disease. The combined
number of patients totals 174 and includes all combined
CEA/CAB cases from 1984 to 1999.
The selection criteria for patients in Group 1 were not
well defined but generally included those with severe cere-
brovascular disease. This group had a high rate of con-
tralateral occlusion (27%) and severe contralateral disease
(16%), preoperative transient ischemia (55%), and preop-
erative stroke (18%). The perioperative death (8%) and
stroke (9%) rates were significantly greater in these
patients compared with those undergoing CAB alone.6
Seven of the nine strokes occurred in patients with preop-
erative symptoms, and the remaining two strokes occurred
in those with contralateral occlusion. In comparison, the
most recent cohort (Group 2) had significantly more uni-
lateral asymptomatic carotid lesions (55%, P < .0001),
fewer preoperative transient ischemic attacks (31%, P <
.002), and fewer preoperative strokes (7%, P < .03). The
incidence of all strokes (1%, P < .032) in Group 2 was sig-
nificantly reduced compared with Group 1, and no ipsilat-
eral strokes were observed. No strokes were observed
among the seven patients with contralateral occlusion in
Group 2. Two patients died of cardiac failure (3% periop-
erative mortality rate), but this was not significantly differ-
ent from the 8% mortality rate seen in Group 1. This trend
toward decreased mortality in the recent cohort occurred
despite a greater proportion of patients requiring urgent
coronary bypass. The stroke and death rates of Group 2
compared with all contemporaneous patients undergoing
CAB alone (2.0% and 2.5%, respectively) were similar.
Other possible explanations for the differences
observed include changes related to technique or staff
involved over the 15-year sampling period. Although
there were some differences in participating surgeons
between the two groups, the general technique for per-
forming CEA has not changed, and the overall stroke rate
for all CEAs performed was similar (< 1.5%).
Our results indicate that outcome after combined
CEA/CAB appears to be related in large part to patient
selection. The two cohorts examined were from the same
institution and had comparable demographic and comor-
bidity characteristics. However, from the standpoint of
cerebrovascular disease, Group 1 was a higher risk because
there were more patients with significant bilateral stenosis
and preoperative symptoms. These results are similar to
data from the Cleveland Clinic, which is one of the few
other studies that examined outcomes after CEA/CAB in
different patient risk groups from the same institution.7
Although our study demonstrates that combined
CEA/CAB can be performed with low stroke and death
rates, particularly in low-risk patients, it does not prove
that performing CEA with CAB reduces the perioperative
stroke rate in susceptible individuals. Such a study would
require a randomized, multi-institutional design with a
large number of patients and is unlikely to be performed.
Also, the etiology of stroke during CAB is multifactorial
and is probably caused most often by atheroembolization
from the ascending aorta during manipulation. Other
causes include air or particulate embolization and hypo-
perfusion. Furthermore, perioperative stroke after com-
bined CAB/CEA seems to occur more commonly in the
contralateral hemisphere or in bilateral “watershed”
zones. In our high-risk patients in Group 1 five of nine
strokes occurred in the contralateral hemisphere, and two
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Table IV. Summary comparison of preoperative symptoms, contralateral carotid status, and complication rates for
Groups 1 and 2
Preoperative Preoperative Asymptomatic Contralateral Ipsilateral
symptoms CVA unilateral stenosis* occlusion All strokes strokes Death
Group 1 55% 18% 20% 27% 9% 4% 8%
Group 2 31% 7% 55% 9% 1% 0% 3%
P < .002† P < .030† P < .0001† P < .004† P < .032† P = .219 P = .138
*Unilateral defined as contralateral carotid < 80% stenosis.
†Considered statistically significant.
CVA, Cerebrovascular accident.
of those patients had contralateral carotid occlusions. The
single stroke that occurred in Group 2 was in the posterior
circulation. Similarly, in Hertzer et al’s study,7 of all
patients who had a stroke after combined CEA/CAB,
only 22% had an isolated infarct in the ipsilateral hemi-
sphere. These results suggest that regional cerebral hypo-
perfusion during cardiopulmonary bypass may play an
important role in stroke after CAB in patients with carotid
artery disease.
Schwartz et al5 examined the outcome of 582 patients
at a Veterans Administration hospital with asymptomatic
carotid stenosis who underwent CAB alone. They found a
10-fold increase (0.34%-3.8%) in hemispheric stroke rates in
patients with any carotid stenosis > 80%. Furthermore, the
stroke rate seemed to increase with a worsening severity of
disease, so that for those with bilateral critical stenosis it was
5.3%. Their observations may be related to more advanced
aortic atherosclerosis in those patients with severe or bilat-
eral carotid stenosis, in addition to implicating the ipsilateral
carotid lesion as a cause for stroke after CAB.
There are several potential strategies for mitigating the
stroke risk in patients with bilateral critical disease or con-
tralateral carotid stenosis. The use of “beating heart” or
“off-pump” CAB, where cardiopulmonary bypass is
avoided, may reduce the stroke risk by maintaining nomi-
nal systemic blood pressure and avoiding aortic cross-
clamping. This technique is now being used frequently at
our institution and elsewhere, but no data are yet available
regarding its impact on perioperative stroke. In patients
with asymptomatic bilateral critical disease, cerebral flow
studies in which transcranial Doppler scan13 or magnetic
resonance imaging14 is used may help identify the hemi-
sphere at greatest risk for ischemia and thus most appro-
priate for combined CEA/CAB. The contralateral CEA
could then be performed postoperatively. Patients with
symptomatic bilateral disease requiring CAB should have
CEA/CAB of the symptomatic hemisphere and subse-
quent contralateral CEA after recovery.
Until a large, randomized, prospective study is per-
formed, controversies will likely persist about the optimal
management of patients with carotid and coronary artery
disease. On the basis of our experience and the available
data, we think combined CEA/CAB is indicated for most
patients with operable carotid lesions. We recognize that
stroke rates may still be higher for patients with bilateral or
severe carotid stenosis, probably because of more
advanced aortic disease, but believe that combined CEA
may confer a benefit in reducing the risk of cerebral
hypoperfusion during cardiopulmonary bypass. Our study
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also demonstrated that in a lower-risk population,
CEA/CAB can be performed with low morbidity and
mortality. The combined approach also confers benefits of
greater patient acceptance and decreased cost by avoiding
a second operation and longer hospital stay.
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Dr R. Clement Darling III (Albany, NY). Jim, another
superb presentation and excellent data from the group at New
England Medical Center. I have one quick question. Since you
did have a significant amount of contralateral strokes, how do you
deal with a patient who presents with bilateral high-grade steno-
sis and going for CABG?
Dr James Estes. I knew you were going to ask this question,
Clem. Dr Darling and the Albany group have been the only peo-
ple to my knowledge who documented bilateral carotid
endarterectomy combined with coronary bypass. I think many of
us are hesitant to do that, but certainly the data regarding that
hypoperfusion in that contralateral hemisphere are compelling
and maybe that could have some benefit.
Dr Darling. Do you do the first one electively and then stage
the second one at the time, or repair them both simultaneously
with CABG?
Dr Estes. If the patient is acceptable from a cardiac standpoint
we will often do a staged procedure first to fix one side and then
fix the other side at the time of their coronary bypass.
Dr Carl Bredenberg (Portland, Me). Excellent presentation.
This is a critical problem: the sequence of intervention for these
two procedures, and you have nicely summarized the fact that
coexistent carotid bifurcation atherosclerosis is a marker for more
severe disease everywhere, and therefore, in general, for a higher
risk for a poor outcome. But if the question is what sequence to
do them or to do them together, have you really shown anything
more than the more severe the atherosclerosis, the poorer the
outcome regardless of what you do?
Ultimately you have two groups, high risk and low risk, and
are there better results in the low-risk than in the high-risk group?
I am not sure that the data really argue or support the conclusion
that the way you did it is any better than any other way. It works,
obviously, and the advantages you enumerated at the end are pre-
sent, but in terms of getting back to the original question, which
sequence is best, I am not sure we can reach conclusions from
these data.
Dr Estes. I appreciate your point. I think anything short of a
randomized, prospective study is going to leave you still dissatis-
fied. At the very least what we have done is come up with a ratio-
nale and a protocol for dealing with these patients and then
justified that protocol with our results.
Dr Antoine Fernini (New Haven, Conn). If you were to do
the carotid first under local, how long do you have to wait for the
CABG, provided the patient is stable for CABG?
Dr Estes. I do not think there is any minimum waiting time.
I think we would proceed within a day or two after the patient has
recovered satisfactorily from the carotid, if we were to do that.
Dr Fernini. I thought you had to wait a couple of weeks
because the intima is still thrombogenic. Is that true or false?
Dr Estes. I am not sure that there are any data to support that.
Dr John Mannick (Boston, Mass). Jim, I think this was an
excellent presentation. I certainly agree with almost everything you
said. I am just wondering, what do you do about that patient group
with the contralateral occlusion, the ipsilateral high-grade stenosis,
and severe coronary disease? We have found, as you have shown, in
that group of patients you are very likely to end up with a nice
endarterectomy, a good coronary bypass, and a severe contralateral
stroke. You clearly are not going to do an endarterectomy in the
occluded carotid. What are you going to do about that patient pop-
ulation?
Dr Estes. The first thing that we do when we encounter such
patients is counsel them and advise them that they are at an
increased risk of stroke by virtue of the diffuse disease and partic-
ularly the contralateral occlusion. We would still proceed with a
combined operation utilizing a shunt on the ipsilateral side and
consider the use of “off-pump” coronary bypass techniques.
Dr Richard Cambria (Boston, Mass). Fine paper, Jim. It is a
pleasure to comment on a paper that agrees with one’s own cur-
rent philosophy, and as you know our group at the MGH has
pretty much been practicing a combined approach for 20 years or
so now. We cannot prove it is the right thing to do, but we think
we have proven it is the safe thing to do.
I have a question about your selection criteria in terms of
fine-tuning patients who might on their own merits walk into
your office and receive a recommendation for a carotid endar-
terectomy. My own personal philosophy has been to do all of the
patients with truly preocclusive lesions. Patients in the less-than-
preocclusive range, where in your own practice you might use
individual selection criteria related to where they sit in that range
of stenosis and their age and comorbidity features, are the tough
ones. So which patients do you recommend a combined proce-
dure, particularly in the severe but perhaps not preocclusive
stenosis group?
Dr Estes. We use the standard criteria with duplex ultrasound,
so that anybody who falls in our 80% to 99% category is consid-
ered suitable for carotid endarterectomy.
Dr Michael Belkin (Boston, Mass). So, Jim it is Thursday
night, and you have an aorta booked at 7:30 and Dr Mackey has
a fem-tib booked at 7:30. The cardiac PA calls you and says, “We
have a patient with an 80% stenosis, asymptomatic, and the other
side is open.” Do you say, “Well, cancel the CABG because the
right thing to do is a combined procedure,” or do you say, “Go
ahead because it is safe, and we’ll fix it later”?
Dr Estes. Your question brings to light some of the peripheral
issues that are involved in the decision making here. Clearly our
cardiac surgeons have been accustomed to this new protocol and
to the extent that if such a patient comes along they would be
reluctant to proceed with the coronary bypass unless the carotid
was fixed as well. In that particular case we would work out a
schedule that was agreeable to both and do the combined
surgery.
Dr Ronald Nath (Medford, Mass). What is your current
approach to the acutely symptomatic carotid patient with severe
coronary disease, since we have been getting more aggressive with
these patients, doing endarterectomies even in the acute state?
Dr Estes. I think that is the patient who is the least contro-
versial, and most agree needs to have combined surgery.
Dr Nath. Does a fresh neurologic deficit dissuade you from
doing the combined surgery?
Dr Estes. It would depend on the extent and the stability of
that neurologic deficit because one would worry about being on
bypass and high degrees of heparinization with a fairly sizable
infarct. Also, our cardiac surgeons as well as others locally have
been doing a lot of off-pump cases. There were none represented
in our study, but I think the implications for reducing preopera-
tive stroke are very real and probably we will see some data within
the next year or two on that subject.
Thank you.
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DISCUSSION
